Results 161 to 170 of about 1,856,875 (191)
Correlation between vascular endothelial growth factor, soluble urokinase plasminogen activator receptor, and tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in group E chronic obstructive lung disease. [PDF]
Rev Assoc Med Bras (1992)Deniz S, Uludağ B, Demirci F.
europepmc +1 more source
Atherosclerosis, 2011 The soluble urokinase plasminogen activator receptor (suPAR) is a plasma marker of low grade inflammation and has been associated with cardiovascular risk.
Allan Linneberg +2 more
exaly +2 more sources
Diabetic Medicine, 2012 Aim: To explore the putative association of new-onset diabetes and the soluble urokinase plasminogen activator receptor (suPAR), which is a new and stable plasma marker of immune function and low-grade inflammation.
Allan Linneberg +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Soluble Urokinase Plasminogen Activator Receptor in Patients With Abdominal Aortic Aneurysm
Thrombosis Research, 2012In the present study we investigated the impact of soluble urokinase plasminogen activator receptor (suPAR) as a biomarker in patients with abdominal aortic aneurysm (AAA) in relation to conventional inflammatory markers, aneurysm size, and rupture.suPAR and conventional inflammatory markers were measured in 119 patients with AAA and 36 controls ...
Anders E Henriksson
exaly +3 more sources
Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism
Thrombosis and Haemostasis, 2016SummaryRaised plasma levels of the soluble urokinase plasminogen activator receptor (suPAR) have been associated with increased incidence of cardiovascular diseases. Whether suPAR is associated with venous thromboembolism (VTE) is largely unknown. The purpose of the present study was to investigate the relationship between suPAR and incidence of VTE in
Gunnar, Engström +4 more
openaire +2 more sources
Soluble urokinase plasminogen activator receptor in blood transfusion components
Transfusion Medicine, 2004Summary. Post‐transfusion infectious complications associated with allogeneic blood components may depend on storage time and may be related to extracellular accumulation of bioactive substances during storage. The glycoprotein, soluble urokinase plasminogen activator receptor (suPAR), which is located in specific granules of neutrophils, plays a role
Riisbro, R. +3 more
openaire +3 more sources
Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children
American Journal of Kidney Diseases, 2020 Soluble urokinase plasminogen activator receptor (suPAR) is a novel biomarker associated with incident chronic kidney disease (CKD) and has been identified as an independent risk factor for CKD progression in children, although these findings remain preliminary, limited to a single point in time, and unreplicated in pediatric cohorts.Prospective ...
Darcy Weidemann +2 more
exaly +4 more sources
Urine Soluble Urokinase Plasminogen Activator Receptor as a Potential Biomarker of Lupus Nephritis Activity [PDF]
Biomarkers, 2021 There is a lack of non-invasive biomarkers to identify lupus nephritis (LN). Soluble urokinase plasminogen activator receptor (suPAR) is a sensitive biomarker of ongoing inflammation and a potential marker of podocyte dysfunction. The aim of this study was to assess urine and plasma suPAR in LN. 14 systemic lupus erythematosus (SLE) patients with newly
László Kovacs +2 more
exaly +4 more sources
Soluble Urokinase Plasminogen Activator Receptor: An Indicator of Pneumonia Severity in Children
2014Enhanced level of soluble urokinase plasminogen activator receptor (suPAR) level has been associated with activation of the immune system. It may be a novel biomarker for pneumonia severity, yet data on this subject are limited. In the present study we seek to determine the suPAR level in hospitalized children with community-acquired pneumonia (CAP ...
A, Wrotek, T, Jackowska, K, Pawlik
openaire +2 more sources
The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers
Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2015Activation of proteolytic mechanisms at the cell surface through the activity of urokinase-type plasminogen activator (uPA) bound to its receptor, uPAR, is an important process in wound healing. The soluble forms of uPAR (suPAR and its fragments I, II, and III) have nonproteolytic functions that include chemotaxis, adhesion, and proliferation, which ...
Ahmad, Anwar +7 more
openaire +3 more sources